Vaccination with appointment
The regular vaccination offers of the district Börde can be booked “online” / vaccines from Biontech (original variant and the adapted vaccines BA1 and BA4 / BA5), Novavax, Johnson and Valneva are vaccinated.
To the online appointment service / please click here
Moderna’s vaccine is not currently offered due to low demand. You can always get vaccinated on Thursdays at the weekly changing locations in Haldensleben, Oschersleben and Wolmirstedt. Vaccination is possible from the age of 5.
Haldensleben: Building Börde County / Bornsche Straße 2 / 39340 Haldensleben
Thursday, October 27, 2022: 2:30 p.m. to 6:30 p.m.
Thursday, November 17, 2022: 2:30 p.m. to 6:30 p.m.
Oschersleben (Bode): Börde District Adult Education Center / Burgbreite 3 / 39387 Oschersleben (Bode)
Thursday, October 13, 2022: 2:30 p.m. to 6:30 p.m.
Thursday, November 3, 2022: 2:30 p.m. to 6:30 p.m.
Thursday, November 24, 2022: 2:30 p.m. to 6:30 p.m.
Wolmirstedt: Social Center (DRK) / Heinrich-Heine-Straße 5 / 39326 Wolmirstedt
Thursday, October 20, 2022: 14:30 to 18:30
Thursday, November 10, 2022: 2:30 p.m. to 6:30 p.m.
The Standing Commission on Vaccination (STIKO) has decided on the 22nd update of the COVID-19 vaccination recommendation and has announced
The Robert Koch Institute (PRKI) website states, “The EU approved Omicron-adapted bivalent mRNA vaccines in September 2022. In the 22nd update of the COVID-19 vaccine recommendation published in Epidemiological Bulletin 40/2022, the STIKO, after reviewing the current data, now recommends preferably one of the licensed and available Omicron-adapted bivalent mRNA vaccines (Comirnaty Original / Omicron BA.1, Comirnaty Original / Omicron BA.4/5, or Spikevax bivalent Original / Omicron BA.1) for booster vaccinations from 12 years of age. In addition, STIKO recommends the use of the adjuvanted dead COVID-19 vaccine Valneva for persons ≥ 18-50 years of age with 2 vaccine doses at least 4 weeks apart as an alternative to the already recommended COVID-19 vaccines for basic immunization against COVID-19.”